Internal Medicine · Brooklyn, NY
NPI
1427056878
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
280 Quentin Rd
Brooklyn, NY, 11223
Phone (718) 336-4499
Groups this clinician bills Medicare through
Medicare paid, 2024
$381K
8,278 services
Medicare patients, 2024
399
Average age 74
Drug cost, 2024
$3.4M
15,945 prescriptions
Company payments, 2025
$407
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mikhail Bernshteyn was code 99439 (chronic, principal, and transitional care management), 1,388 times for 81 patients. In total Mikhail Bernshteyn billed 8,278 services in 63 codes, and Medicare paid $381K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-22.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,388 | 81 | $40.86 | $57K |
| 99213 Office E&M - Established | Office | 1,283 | 345 | $69.96 | $90K |
| 99212 Office E&M - Established | Office | 1,170 | 279 | $46.87 | $55K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 813 | 81 | $53.03 | $43K |
| 94060 Pulmonary Function Testing | Office | 395 | 258 | $30.43 | $12K |
| 94727 Pulmonary Function Testing | Office | 385 | 256 | $35.38 | $14K |
| 94729 Pulmonary Function Testing | Office | 384 | 256 | $47.12 | $18K |
| 94640 Treatment - Miscellaneous | Office | 353 | 182 | $6.92 | $2,444 |
| 94667 Pulmonary | Office | 249 | 153 | $21.23 | $5,288 |
| 36415 Venipuncture Blood Collection | Office | 205 | 151 | $8.65 | $1,773 |
| 94664 E&M - Miscellaneous | Office | 182 | 142 | $15.47 | $2,815 |
| 93000 Electrocardiogram | Office | 134 | 114 | $9.73 | $1,304 |
| 98927 Spinal Manipulation | Office | 112 | 45 | $47.69 | $5,341 |
| J7120 Ringers lactate infusion, up to 1000 cc | Office | 110 | 40 | $1.83 | $202 |
| 96365 Intravenous Infusion, Hydration | Office | 110 | 40 | $53.00 | $5,830 |
By year: 2022 $492K for 9,393 services; 2023 $359K for 6,982 services; 2024 $381K for 8,278 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 205 | 151 | $8.65 | $1,773 |
| 82962 Clinical Chemistry | 54 | 42 | $3.21 | $173 |
Medicare prescription drug claims, 2024
In 2024, the drug Mikhail Bernshteyn prescribed most often to Medicare patients was Amlodipine Besylate, with 441 prescriptions and refills. In total Mikhail Bernshteyn wrote 15,945 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 441 | 609 | 75 | $1,075 |
| Atorvastatin Calcium Generic | 439 | 665 | 77 | $2,361 |
| Diclofenac Sodium Generic | 429 | 466 | 77 | $135K |
| Linzess Linaclotide | 358 | 382 | 42 | $195K |
| Metoprolol Succinate Generic | 351 | 502 | 60 | $3,137 |
| Zolpidem Tartrate Generic | 331 | 331 | 51 | $1,109 |
| Creon Lipase/Protease/Amylase | 312 | 364 | 47 | $520K |
| Losartan Potassium Generic | 310 | 420 | 58 | $1,020 |
| Rosuvastatin Calcium Generic | 310 | 421 | 57 | $1,733 |
| Dexlansoprazole Dr Dexlansoprazole | 293 | 320 | 38 | $51K |
| Metoprolol Tartrate Generic | 271 | 347 | 47 | $618 |
| Levothyroxine Sodium Generic | 269 | 375 | 43 | $1,630 |
| Simvastatin Generic | 238 | 338 | 37 | $536 |
| Clonidine Hcl Generic | 229 | 273 | 37 | $632 |
| Omeprazole Generic | 224 | 286 | 44 | $992 |
Brand drugs: 3,882 claims; generic drugs: 11,862 claims; opioid claims: 248.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mikhail Bernshteyn $407 ($407 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $211.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.